Plan B Switch In Canada Driving Down Costs – Preliminary Study Results
This article was originally published in The Tan Sheet
Executive Summary
The nonprescription availability of Barr Labs' Plan B in Canada is resulting in cost-savings for the country's healthcare system, according to preliminary results from a study conducted by Judith Soon, PhD, University of British Columbia